Covetrus

Covetrus Branded Products - Second Edition

Covetrus Branded Products portfolio offers hundreds of low-cost, high-quality products help you maintain fee schedules and increase business profitability.

Issue link: https://www.e-digitaleditions.com/i/1465948

Contents of this Issue

Navigation

Page 140 of 169

141 2022 | Covetrus Brand Catalog Can't find what you are looking for? Contact your Covetrus North America representative. Quadruple Topical Ointment provides four therapeutic effects, including anti-inflammatory, antipruritic, antifungal, and antibacterial Indicated for: Local therapy in a variety of cutaneous disorders of cats and dogs, disorders caused, complicated, or threatened by bacterial and/or candidal (monilial) infections Treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs and in anal gland infections of dogs Management of dermatologic disorders characterized by inflammation and dry or exudative dermatitis Eczematous dermatitis, contact dermatitis, and seborrheic dermatitis For use as an adjunct in the treatment of dermatitis due to parasitic infection Important Note: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metris. Avoid oral ingestion. Corticosteroids administered to dogs, rabbits, and rodents during pregnancy have resulted in cleft palate in offspring. In dogs, other congenital anomalies have resulted. Quadruple topical ointment is not intended for treatment of deep abscesses or deep-seated infections. Quadruple Topical Ointment P R O P E T S O LU T I O N S

Articles in this issue

Archives of this issue

view archives of Covetrus - Covetrus Branded Products - Second Edition